Rashmi Verma, M.D., F.A.C.P.
Associate Professor
To see if Rashmi Verma is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Specialties
Medical Oncology
Bladder
Colorectal (Colon)
Esophageal (Throat)
Liver
Pancreas
Prostate
Stomach
Department
Locations and Contact
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Phone: 916-734-5959
Philosophy of Care
She is a strong advocate for patients and believes in treating not only the medical condition but patient in total. Each patient requires a varied amount of physical, emotional, psychological, and social support. She believes that patient has equal right in making decisions regarding treatment options.
Clinical Interests
Dr. Rashmi Verma is medical oncologist offering care for patients with gastrointestinal cancers such as colon, rectal, anal, esophageal, gastric, pancreatic, liver, cholangiocarcinoma and genitourinary prostate cancers.
Research/Academic Interests
Dr. Rashmi Verma's areas of interest include colo-rectal, esophageal-gastric, pancreatic, liver, cholangiocarcinoma, anal and prostate cancer. She is active in SWOG clinical trial meetings and ASCO American society of clinical oncology gastro intestinal meetings and ASCO advocacy meetings. She is actively involved in teaching and traning medical students, residents and fellows, and the younger generation of doctors and oncologists.
Division
Hematology and Oncology
Center/Program Affiliation
Medical School
M.B.B.S., University College of Medical Sciences, Delhi University, Delhi, India 1994
Internship
Internal Medicine (PGY1-2), University of South Dakota and VA Hospital, Sioux Falls SD 2009-2011
Residency
Internal Medicine (PGY3), University of Medicine and Dentistry of New Jersey and Cooper University Hospital, Camden NJ 2011-2012
Fellowship
Hematology & Oncology, Texas Tech University, Lubbock TX 2013-2016
Chief Fellow during Hematology & Oncology Fellowship,
Fellow of American College of Physicians,
Soufi K, Abbasi F, Wei D, Verma R. Rectal Melanoma: Rare Cancer with Grave Prognosis, Case Rep Gastroenterology. 2023 Jun 13;17(1):235-241. doi: 10.1159/000529434. PMID: 37383983 PMCID: PMC10294269
Batra N, Kumar V, Nambiar R, De Souza C, Yuen A, Le U, Verma R, Ghosh P, Vinall R. Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review. Ann Transl Med. 2022 Jul;10(13):754. doi: 10.21037/atm-22-94.PMID: 35957716 PMCID: PMC9358515 DOI: 10.21037/atm-22-94.
Verma R. Neoadjuvant Cabozantinib in Renal Cell Carcinoma: A Case Series and Review of Literature. Clin Genitourinary J. 2020 April.
Mariam Roy A, Briggler A, Tippit D , Dawson K, Verma R. Neoadjuvant Cabozantinib in Renal-Cell Carcinoma: A Brief Review, Clin Genitourin Cancer. 2020 Dec;18(6):e688-e691. doi: 10.1016/j.clgc.2020.04.003. Apr 21. PMID: 32660880
Lu C, Figueroa JA, Liu Z, Konala V, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection. Curr Cancer Drug Targets. 2015;15(7):575-92. doi:10.2174/156800961507150828223554. PMID:26324128.
Mirandola L, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, Cobos E, Jenkins MR, Chiriva-Internati M. Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium. Int Rev Immunol. 2015 Mar;34(2):134-42. doi:10.3109/08830185.2015.1018417. PMID:25901858.
Lu C, Figueroa J, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection, Curr Cancer Drug Targets. 2015;15(7):575-92. doi: 10.2174/156800961507150828223554. PMID: 26324128
Soape M, Verma R, Payne J, Cobos E. Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine, Case Rep Gastrointest Med. 2015; doi: 10.1155/2015/326795. PMID: 26167310 PMCID:PMC4488146
Cobos E, Figueroa J, Mirandola L, Verma R. International Reviews of Immunology: co-author: The Role of Human Papilloma Virus (HPV) Infection in Non- Anogenital cancer and the Promise of Immunotherapy: A Review. International Reviews of Immunology. 2014;33(5).